AssetMark Inc’s Aurora Cannabis ACB Stock Holding History

AssetMark Inc’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10	Closed	-$33	–	3556
2026 Q1	$33	Buy	10 +8	+400%	+$30	﹤0.01%	3411
2025 Q4	$8	Hold	2	–	–	﹤0.01%	3362
2025 Q3	$12	Buy	+2	New	+$10	﹤0.01%	3172

Other funds holding ACB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

AssetMark Inc's ACB Position: Q2 2026 in Review

AssetMark Inc sold out of Aurora Cannabis (ACB) in Q2 2026, closing a stake of 10 shares — an estimated $33 sold.

AssetMark Inc first reported a position in ACB in Q3 2025 and held it in 3 quarters. The position peaked at $33 in Q1 2026. 148 funds tracked by Wall St. Rank hold ACB as of Q2 2026.

AssetMark Inc reported no remaining Aurora Cannabis position as of Q2 2026 after selling out during the quarter.
AssetMark Inc sold 10 Aurora Cannabis shares in Q2 2026, an estimated $33.
AssetMark Inc first reported a position in Aurora Cannabis in Q3 2025 and held it in 3 quarters.
AssetMark Inc's Aurora Cannabis position peaked at $33 in Q1 2026.
148 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.